Share Prices & Company Research

Stockbroking

Shire

Current Price 4584.50p Bid 4562.50p Ask 4563.00p Change -1.26%
Last Updated: 18/11/2018 01:19. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Shire plc (formerly Shire Pharmaceuticals Group plc) is the leading global biotechnology company focused on serving people with rare diseases. It strives to develop best-in-class products, many of which are available in more than 100 countries, across core therapeutic areas including Immunology, Hereditary Angioedema, Hematology, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine / Endocrine, Ophthalmics, a growing franchise in Oncology, and Neuroscience.

Financial Highlights Year Ended 31/12/2017

Turnover
£15,160.60m
Operating Profit
£2,455.20m
Dividend Yield
0.36
Dividend Per Share
25.31
Dividend Cover
18.31
P/E Ratio
9.81

Key Personnel

Dr Flemming Ornskov
Chief Executive Officer
Thomas Johannes Willi Dittrich
Chief Financial Officer
Susan Rachel Kilsby
Non-Executive Chairman
Ian Clark
Non-Executive Director
Dominic William Blakemore
Non-Executive Director
Olivier Jean Bohuon
Non-Executive Director
William M Burns
Non-Executive Director
Gail Fosler
Non-Executive Director
Dr Steven Gillis
Non-Executive Director
Dr David S Ginsburg
Non-Executive Director
Sara Mathew
Non-Executive Director
Anne Elizabeth Minto
Non-Executive Director
Albert Stroucken
Non-Executive Director

Stock Details

EPIC
SHP
ISIN
JE00B2QKY057
Shares in Issue
914,818,708
Market cap
£42,273.77m

Analyst Views (5)

Strong Buy
 
40.00%
Buy
 
20.00%
Hold
 
40.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
4563.00p
Bid Price
4562.50p
Ask Price
4563.00p
Volume
3360329
Change Today
-58.00p
% Change Today
-1.26%
Open
4626.00p
Previous Close
4563.00p
Intraday High
4650.00p
Intraday Low
106.50p
52 Week High
4780.00p
52 Week Low
2940.50p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Shire Intra-day Chart

Shire News

News in this section is provided by MoneyAM

Shire to present data on treatment for rare disease HAE at Seattle conference 16 Nov 2018 | 08:08 Shire gets European nod for hereditary angioedema treatment 19 Oct 2018 | 13:08 FTSE climbs higher on falling pound as 'no deal' fears rise 21 Sep 2018 | 17:03 Miners underpin strong open for UK stocks 21 Sep 2018 | 09:05 Shire gets Japan regulatory nod for hereditary angioedema treatment 21 Sep 2018 | 07:19 Miners boost FTSE as investors shrug off trade war drama 18 Sep 2018 | 12:00 Shire gets European marketing nod for von Willebrand disease treatment 12 Sep 2018 | 07:06 Broker Forecast - Berenberg issues a broker note on Shire PLC 07 Sep 2018 | 08:40 Storm clouds gather as the FTSE falls 31 Aug 2018 | 11:58 Shire completes sale of oncology unit to Servier for $2.4bn 31 Aug 2018 | 07:45 FTSE heads for strong Friday finish 24 Aug 2018 | 16:41 Miners boost FTSE ahead of Bank Holiday weekend 24 Aug 2018 | 11:45 UK stocks open flat as miners rise, house builders fall 24 Aug 2018 | 08:51 Shire gets FDA approval for hereditary angioedema treatment 24 Aug 2018 | 08:38 FTSE struggles as Turkey's emergency measures fail to reassure investors 13 Aug 2018 | 16:46 FTSE declines on Turkey woes 13 Aug 2018 | 12:07 Shire partner Shionogi submits new drug application in Japan for ADHD treatment 13 Aug 2018 | 07:07 Broker Forecast - Barclays Capital issues a broker note on Shire PLC 10 Aug 2018 | 08:40 Broker Forecast - Deutsche Bank issues a broker note on Shire PLC 01 Aug 2018 | 09:10 Shire profit more than doubles after higher immunology sales 31 Jul 2018 | 13:11 Broker Forecast - Barclays Capital issues a broker note on Shire PLC 10 Jul 2018 | 10:40 Miners struggle amid falling metal prices 28 Jun 2018 | 16:55 FTSE hit by weaker miners 28 Jun 2018 | 11:46 UK stocks open 0.3% higher as Greece gets debt relief 22 Jun 2018 | 09:04 Shire releases retrospective study results of pancreatic cancer records 22 Jun 2018 | 07:11 Decline in banks and housebuilding stocks threaten to drag FTSE lower 21 Jun 2018 | 12:02 Broker Forecast - Shore Capital issues a broker note on Shire PLC 21 Jun 2018 | 10:20 FTSE rises ahead of Bank of England interest rate meeting 21 Jun 2018 | 09:11 Shire announces FDA approval for a label expansion for CINRYZE 21 Jun 2018 | 07:57 Shire presents new data on the treatment of chronic hypoparathyroidism 22 May 2018 | 13:09

Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Tangible Assets
6,635.4
6,469.6
Intangible Assets & Goodwill
52,877.7
52,585.7
Investments & Other Non-Current Assets
635.3
440.6
Total Non-Current Assets
60,148.4
59,495.9
Inventory
3,291.5
3,562.3
Trade & Receivables
3,009.8
2,616.5
Cash & Receivables
472.4
528.8
Other Current Assets & Assets Held for Resale
834.8
831.9
Total Assets
67,756.9
67,035.4

Liabilities (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Short Term Liabilities
7,882.0
7,743.3
Long Term Liabilities
23,698.5
30,344.1
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
31,580.5
38,087.4

Net Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Net Assets
36,176.4
28,948.0

Equity (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Share Capital
81.6
81.3
Minority Interests
0.0
0.0
Retained Earnings
9,920.6
5,925.3
Share Premium Account
0.0
0.0
Other Equity
26,174.2
22,941.4
Total Equity
36,176.4
28,948.0

Cashflow (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Cashflow from Operating Activities
4,256.7
2,658.9
Cashflow Before Financing
3,485.8
-15,433.3
Increase / Decrease in Cash
-56.4
393.3

Income (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Turnover
15,160.6
11,396.6
Cost of Sales
4,700.8
3,816.5
Gross Profit
10,459.8
7,580.1
Operating Profit
2,455.2
9,629.0
Pre-Tax Profit
1,893.4
486.1
Profit / Loss for the Year
4,271.5
327.4

Dividend History

Data has been provided by MoneyAM

Period
Ex-Dividend Date
Payment Date
H1 Dividend
06 Sep 2018
19 Oct 2018
H2 Dividend
08 Mar 2018
24 Apr 2018
H1 Dividend
07 Sep 2017
20 Oct 2017
H2 Dividend
09 Mar 2017
25 Apr 2017
H1 Dividend
08 Sep 2016
07 Oct 2016
H2 Dividend
10 Mar 2016
12 Apr 2016
H1 Dividend
03 Sep 2015
02 Oct 2015
H2 Dividend
12 Mar 2015
14 Apr 2015
H1 Dividend
03 Sep 2014
03 Oct 2014
H2 Dividend
05 Mar 2014
08 Apr 2014
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.